Clinical trial Recruiting at 1 site Observational Ages 18 and up

Mouth bacteria and carotid artery plaque vulnerability

Official title: The Role of the Oral Microbiome in Carotid Atherosclerosis: Investigating in a Cross-sectional Study the Microbial Influence on Plaque Development and Vulnerability Based on Biobank Data

Run by Semmelweis University Heart and Vascular Center · NCT07296965 · Data updated 2026-11-12

This project will see if mouth bacteria are linked to vulnerable carotid plaques in adults having carotid endarterectomy at Semmelweis University.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment200 (estimated)
SponsorSemmelweis University Heart and Vascular Center
Academic / other
Locations1 site (Budapest)
StatusRecruiting
StartedNovember 1, 2025
Main results expectedNovember 1, 2027
Study endsNovember 1, 2029
Registry record updatedApril 22, 2026
Trial IDNCT07296965 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18) scheduled for carotid endarterectomy at Semmelweis University with confirmed internal carotid artery stenosis who can provide informed consent and are eligible for surgery.

Probably not a fit

People without carotid stenosis, those not undergoing endarterectomy, or those excluded by recent antibiotics, active infections, immunosuppression, pregnancy, prior ipsilateral carotid surgery, or MRI incompatibility are unlikely to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

OMICA is an observational cross-sectional project enrolling adults undergoing carotid endarterectomy at Semmelweis University's Városmajor Heart and Vascular Center and participating in the Carotid Biobank. Preoperative photon-counting CTA confirms internal carotid stenosis, while non-invasive MRI and ultrasound are used to classify plaques as vulnerable or stable; all imaging is anonymized. Investigators collect oral health information and multiple biological samples — oral, anal, urine, blood, and excised carotid plaque tissue during surgery — for microbiome sequencing. The analysis compares bacterial communities between vulnerable and stable plaques and between plaque and oral sites to identify taxa associated with plaque vulnerability.

Why it matters

Potential benefit: If successful, the findings could enable new biomarkers or prevention strategies linking oral health to stroke risk and help clinicians better identify patients at higher risk of plaque rupture.

How similar studies have gone: Previous observational studies have reported associations between periodontal pathogens and atherosclerotic plaques, but direct evidence linking oral bacteria to plaque rupture remains limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Confirmed internal carotid artery (ICA) stenosis on preoperative photon-counting computed tomography (CTA)
* Adults (≥18 years) undergoing carotid endarterectomy at Semmelweis University.
* Eligible for surgery based on standard anesthesiologic evaluation.
* Willing and able to provide written informed consent for participation and sample collection.

Exclusion Criteria:

* Active systemic infection or current antibiotic therapy within 30 days before surgery.
* Immunosuppressive therapy or immunodeficiency disorders.
* Inability to undergo MRI (e.g., pacemaker, metallic implants, severe claustrophobia).
* Pregnancy or lactation.
* Malignancy under active treatment.
* Prior carotid surgery or stenting on the same side.
* Refusal or inability to provide informed consent.

Where it's running

  • Városmajor Heart and Vascular Center, Semmelweis University
    Budapest, Hungary
    Recruiting

Study contacts

  • Principal investigator: Péter Sótonyi, MD, DSc — Semmelweis University Heart and Vascular Center
  • Study coordinator: Zsuzsanna Németh, MD, PhD
  • Email: zsuzsannamihaly@gmail.com
  • Phone: +36-30-261-1559

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.